Norepinephrine Bitartrate Injection Recalled for Defective Container
Athenex Pharma Solutions is recalling Norepinephrine Bitartrate Injection 8 mg per 250 mL due to a defective container. The recall affects approximately 9,800 bags distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a Class II recall with no reported illnesses or injuries. The hazard—a defective container—is a manufacturing/packaging issue without evidence of actual harm. Class II recalls with no hospitalization reports and no injury reports fall into the Moderate category.
Plain-English summary
Athenex Pharma Solutions, LLC is recalling Norepinephrine Bitartrate Injection 8 mg per 250 mL in 0.9% Sodium Chloride (NDC 76154-475-15) in 250 mL excel bags due to a defective container. Approximately 9,800 bags have been distributed nationwide.
Specific lot numbers affected are: F2101639, F2101642, F2101644, F2101645 (expiration 4/30/22); F2101674, F2101675, F2101676 (expiration 5/05/22); F2101790, F2101791, F2101792, F2101793, F2101794 (expiration 5/26/22); and F2101813 (expiration 5/29/22).
This is a voluntary, Class II recall initiated by the firm on March 14, 2022. Healthcare providers and patients should not use affected lots and should return them to Athenex Pharma Solutions, LLC for replacement or credit. Anyone with questions should contact the manufacturer at Athenex Pharma Solutions, LLC in Clarence, NY.
The recalled product
- Product
- Norepinephrine Bitartrate Injection 8 mg per 250 mL in 0.9% Sodium Chloride, 8 mg, 250 mL excel bag, Rx only, Athenex Pharma Solutions, LLC, Clarence, NY, 14031, NDC 76154-475-15
- Manufacturer
- Athenex Pharma Solutions, LLC
- Hazard
- defective-container
- packaging-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (17)
- Lot #: F2101639
- F2101642
- F2101644
- F2101645
- Exp 4/30/22
- F2101674
- F2101675
- F2101676
- Exp 5/05/22
- F2101790
- F2101791
- F2101792
- F2101793
- F2101794
- Exp 5/26/22
- F2101813
- Exp 5/29/22
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27